Endocrine resistance in breast cancer From cellular signaling pathways to epigenetic mechanisms

被引：27

作者：

Bianco, Stephanie ^{[1
]}

Gevry, Nicolas ^{[1
]}

机构：

[1] Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ, Canada

来源：

TRANSCRIPTION-AUSTIN | 2012年 / 3卷 / 04期

关键词：

endocrine resistance; breast cancer; transcription factor; epigenetic; genomic; chromatin;

D O I：

10.4161/trns.20496

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Although multiple cellular mechanisms have been proposed to explain endocrine resistance in breast cancer, the genomics events promoting the dys-regulation of gene expression pattern are not clearly understood. Because chromatin plays a dynamic role in the estrogen receptor alpha (ER alpha) transcriptional program, we herein review signaling pathways implicated in endocrine resistance and try to merge them with recent epigenetic studies.

引用

页码：165 / 170

页数：6

共 45 条

[11] Histone H2A.Z is essential for estrogen receptor signaling [J].

Gevry, Nicolas ;

Hardy, Sara ;

Jacques, Pierre-Etienne ;

Laflamme, Liette ;

Svotelis, Amy ;

Robert, Francois ;

Gaudreau, Luc .

GENES & DEVELOPMENT, 2009, 23 (13) :1522-1533

[12] Phosphorylation of the oestrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer [J].

Holm, C. ;

Kok, M. ;

Michalides, R. ;

Fles, R. ;

Koornstra, R. H. T. ;

Wesseling, J. ;

Hauptmann, M. ;

Neefjes, J. ;

Peterse, J. L. ;

Stal, O. ;

Landberg, G. ;

Linn, S. C. .

JOURNAL OF PATHOLOGY, 2009, 217 (03) :372-379

[13] Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen [J].

Hurtado, Antoni ;

Holmes, Kelly A. ;

Geistlinger, Timothy R. ;

Hutcheson, Iain R. ;

Nicholson, Robert I. ;

Brown, Myles ;

Jiang, Jie ;

Howat, William J. ;

Ali, Simak ;

Carroll, Jason S. .

NATURE, 2008, 456 (7222) :663-U93

[14] FOXA1 is a key determinant of estrogen receptor function and endocrine response [J].

Hurtado, Antoni ;

Holmes, Kelly A. ;

Ross-Innes, Caryn S. ;

Schmidt, Dominic ;

Carroll, Jason S. .

NATURE GENETICS, 2011, 43 (01) :27-U42

[15] G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer [J].

Ignatov, Atanas ;

Ignatov, Tanja ;

Weissenborn, Christine ;

Eggemann, Holm ;

Bischoff, Joachim ;

Semczuk, Andrzej ;

Roessner, Albert ;

Costa, Serban Dan ;

Kalinski, Thomas .

BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) :457-466

[16] Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells [J].

Ignatov, Atanas ;

Ignatov, Tanja ;

Roessner, Albert ;

Costa, Serban Dan ;

Kalinski, Thomas .

BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (01) :87-96

[17] PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer [J].

Kok, Marleen ;

Zwart, Wilbert ;

Holm, Caroline ;

Fles, Renske ;

Hauptmann, Michael ;

Van't Veer, Laura J. ;

Wessels, Lodewyk F. A. ;

Neefjes, Jacques ;

Stal, Olle ;

Linn, Sabine C. ;

Landberg, Goran ;

Michalides, Rob .

BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) :1-12

[18] Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors [J].

Le Romancer, Muriel ;

Poulard, Coralie ;

Cohen, Pascale ;

Sentis, Stephanie ;

Renoir, Jack-Michel ;

Corbo, Laura .

ENDOCRINE REVIEWS, 2011, 32 (05) :597-622

[19] Growth factor stimulation induces a distinct ERα cistrome underlying breast cancer endocrine resistance [J].

Lupien, Mathieu ;

Meyer, Clifford A. ;

Bailey, Shannon T. ;

Eeckhoute, Jerome ;

Cook, Jennifer ;

Westerling, Thomas ;

Zhang, Xiaoyang ;

Carroll, Jason S. ;

Rhodes, Daniel R. ;

Liu, X. Shirley ;

Brown, Myles .

GENES & DEVELOPMENT, 2010, 24 (19) :2219-2227

[20] PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer [J].

Magnani, Luca ;

Ballantyne, Elizabeth B. ;

Zhang, Xiaoyang ;

Lupien, Mathieu .

PLOS GENETICS, 2011, 7 (11)

← 1 2 3 4 5 →